The human papillomavirus (HPV) is a common sexually transmitted infection and has affected almost 80 million Americans. Despite the availability of a well-studied, safe, and effective vaccine to prevent the HPV infection since 2006, the national HPV vaccination coverage is below 50% among adolescents. Due to a lack of immunization, many people have experienced HPV-related health problems, including genital warts and cancers. Studies also report that HPV vaccination rates continue to lag among United States military members. We reviewed the literature to understand further the impact that bundle interventions have on HPV vaccine uptake (next due dose 1, 2, or 3) in females. Research shows that multi-component interventions are more effective...
Human papillomavirus (HPV) is the most common sexually transmitted infection in the world and in the...
Human papillomavirus (HPV) is a common sexually transmitted disease that affects more than 75% of pe...
Human papilloma virus (HPV) vaccine was developed to reduce HPV-attributable cancers, external genit...
An estimated 85% of unvaccinated sexually active individuals will acquire Human Papillomavirus (HPV)...
Background: Human papillomavirus (HPV) is the most commonly sexually transmitted infection in the U...
The HPV vaccine is effective in preventing HPV-related cancers. Vaccination rates are low in women a...
Project Purpose: The purpose of the project was to implement Human Papillomavirus (HPV) patient educ...
Despite national guidelines and proven health benefits, vaccination rates for the human papillomavir...
The nonavalent human papilloma virus (HPV) vaccination prophylactically contributes to the preventio...
Human Papilloma Virus (HPV) is an insidious and nearly ubiquitous sexually transmitted infection (ST...
abstract: Human papillomavirus (HPV) is a prevalent sexually transmitted infection that affects many...
Human papillomavirus (HPV) infection is the most prevalent of all sexually transmitted infections in...
The most common sexually transmitted infection in the United States is human papillomavirus (HPV). T...
Background Introduction • Between 2013 and 2017 about 45 000 HPV related cancers were diagnosed in ...
Human papillomavirus (HPV) infection is the most common sexually transmitted infection worldwide. Al...
Human papillomavirus (HPV) is the most common sexually transmitted infection in the world and in the...
Human papillomavirus (HPV) is a common sexually transmitted disease that affects more than 75% of pe...
Human papilloma virus (HPV) vaccine was developed to reduce HPV-attributable cancers, external genit...
An estimated 85% of unvaccinated sexually active individuals will acquire Human Papillomavirus (HPV)...
Background: Human papillomavirus (HPV) is the most commonly sexually transmitted infection in the U...
The HPV vaccine is effective in preventing HPV-related cancers. Vaccination rates are low in women a...
Project Purpose: The purpose of the project was to implement Human Papillomavirus (HPV) patient educ...
Despite national guidelines and proven health benefits, vaccination rates for the human papillomavir...
The nonavalent human papilloma virus (HPV) vaccination prophylactically contributes to the preventio...
Human Papilloma Virus (HPV) is an insidious and nearly ubiquitous sexually transmitted infection (ST...
abstract: Human papillomavirus (HPV) is a prevalent sexually transmitted infection that affects many...
Human papillomavirus (HPV) infection is the most prevalent of all sexually transmitted infections in...
The most common sexually transmitted infection in the United States is human papillomavirus (HPV). T...
Background Introduction • Between 2013 and 2017 about 45 000 HPV related cancers were diagnosed in ...
Human papillomavirus (HPV) infection is the most common sexually transmitted infection worldwide. Al...
Human papillomavirus (HPV) is the most common sexually transmitted infection in the world and in the...
Human papillomavirus (HPV) is a common sexually transmitted disease that affects more than 75% of pe...
Human papilloma virus (HPV) vaccine was developed to reduce HPV-attributable cancers, external genit...